Bookmark and Share

Windows of opportunity

Investing in discovery

ian crozier

Caring for veterans

Emory’s Veterans Program provides vital mental health treatment for post-9/11 veterans and their families as a member of the Warrior Care Network. For every dollar the program raises, the Wounded Warrior Project adds two dollars, up to $15 million. Unrestricted gifts support transportation, lodging, and meals for out-of-town veterans who are receiving intensive treatment; prescription medications or co-pays to eliminate financial barriers to care; and alternative treatment options.  

Find out more from Courtney Harris, director of development, at 404.727.5282 or courtney.harris@emory.edu.



Getting through the night

Getting enough hours of sleep is critical to health and so are the quality of those hours. The Emory Sleep Center researchers and doctors study the sleep cycle so that patients can be tested and treated using the most up-to-date methods.  

Courtney Harris, director of development, can provide more information at 404.727.5282 or courtney.harris@emory.edu.



Treating Melanoma

When President Jimmy Carter sought treatment for melanoma at Winship Cancer Institute, he turned to medical oncologist David Lawson, who leads a melanoma program that incorporates the best of basic and clinical science with the goal of improving the care of patients with melanoma. His active melanoma working group funds seed grants for basic or clinical research, and also participates in and leads clinical trials at all phases of therapy development.

For more information on supporting melanoma research at Emory, contact B. Alexander Brown 00C, assistant vice president for development, at 404.712.8822 or babrown@emory.edu.




Michael Frankel

Saving lives after stroke

A team led by Emory neurologist Michael Frankel, the director of the Marcus Stroke and Neuroscience Center at Grady Memorial Hospital, pioneered the thrombectomy method to directly remove blood clots and improve outcomes for stroke patients. Another effective treatment—a clot-busting medicine called intravenous tPA—got its start in the Frankel group.

To support Emory research and progress in stroke treatment, contact Katie Dozier, director of development, at 404.712.2211 or katie.dozier@emory.edu.

Email the editor